The upcoming report from Doximity (DOCS) is expected to reveal quarterly earnings of $0.44 per share, indicating a decline of 2.2% compared to the year-ago period. Analysts forecast revenues of $181.03 million, representing an increase of 7.4% year over year.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific Doximity metrics that are routinely monitored and predicted by Wall Street analysts.
The consensus among analysts is that 'Revenues- Other' will reach $8.19 million. The estimate points to a change of +29.2% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenues- Subscription' of $173.19 million. The estimate indicates a change of +6.7% from the prior-year quarter.
According to the collective judgment of analysts, 'Number of customers with at least $500,000 of revenue' should come in at 129 . The estimate compares to the year-ago value of 114 .
View all Key Company Metrics for Doximity here>>>
Over the past month, Doximity shares have recorded returns of -13.4% versus the Zacks S&P 500 composite's +0.7% change. Based on its Zacks Rank #2 (Buy), DOCS will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Doximity, Inc. (DOCS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
